Wilson Sonsini - ECP

insight detail

Wilson Sonsini Advises on Monte Rosa Therapeutics’ $96 Million Series B Financing

  • 09/23/20
  • Client Highlights
  • Biotech
  • Life Sciences
  • Investment Services

ECP Attorneys:

Copyright © 2022 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.

We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content. For more information or to opt-out, visit our privacy policy.